Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- China Medical Reports Positive Results for Ongoing Business
- ChinaBio Today submits: As promised earlier, China Medical Technologies CMED released selected Q2 (ended September 30, 2008) results, though a full disclosure, complete with analysts’ call, will wait until December 18. The problem with a full release is reporting issues: China Medical is deciding how to account for its...
- External links 2008-11-18
- Genesis Pharma Reports Improved Q1
- ChinaBio Today submits: Genesis Pharmaceuticals Enterprises, Inc. (GNPH.OB) reported that Q1 (ended September 30, 2008) revenues climbed an admirable 66% to $27.6 million, and gross profit rose an even more dramatic 81% to $21.8 million. On a non-GAAP basis, Genesis reported net income of $4.8 million a 50% increase....
- External links 2008-11-18
- WuXi Misses Q3 Forecast, Guides Lower for Year
- ChinaBio Today submits: WuXi PharmaTech WX released weaker-than-expected financial Q3 results unaudited and, at the same time, lowered guidance for its full year. The company reduced its forecast for 2009 revenue by $20 to $35 million. The new revenue range is expected to be between $260 and $265 million,...
- External links 2008-10-15
- China Med Forecasts Increased Revenues for 2009 Despite Low Q3
- ChinaBio Today submits: China Medicine Corporation (CHME.OB) said a delay in a provincial bidding system caused its Q3 revenues to fall 17% to $10.5 million. Even though margins rose slightly, the increases were not enough to offset Q3’s lower revenues. As a result, net income dipped 10% to $2...
- External links 2008-11-16
- Shengtai Pharma Considers Business Disruptions Temporary
- ChinaBio Today submits: Shengtai Pharmaceutical, Inc. (SGTI.OB) reported that the August Olympics caused a slowdown in its fiscal year 2009 Q1 (ended September 30, 2008) financial performance. The government restrictions on manufacturing and transportation, put in place in Beijing to reduce pollution, disrupted normal business activity. As a result,...
- External links 2008-11-16
- BMP Sunstone's Q3: Revenues on the Rise
- ChinaBio Today submits: BMP Sunstone Corporation BJGP, a company that has been building itself through acquisitions over the last two years, announced very strong Q3 results. It was the first quarter in which results included participation from BMP Sunstone’s acquisition of drug distributor Rongheng. Sunstone announced it acquired a...
- External links 2008-11-12
- Tinayin Reports Higher Revenue and Costs
- ChinaBio Today submits: Tianyin Pharmaceutical Co. TPI reported higher results for the first quarter of 2009 fiscal year. Revenues rose 33 % to $9.6 million, while net income increased at a slower pace, rising 11% to $1.8 million. However, because the number of shares outstanding almost doubled to 24.6...
- External links 2008-11-11
- Mindray's Q3 Leaves Investors Less Than Pleased
- ChinaBio Today submits: On the face of it, the Q3 financial report issued by Mindray Medical International MR was very positive. Revenues were up 94% at $146.5 million and non-GAAP net income climbed a smaller but still respectable 48% to $33.7 million. Nevertheless, Mindray’s stock price suffered in the...
- External links 2008-11-11
- China Pharma Reports Improved Q3, Accounts Receivable Also Up
- ChinaBio Today submits: China Pharma Holdings (CPHI.OB) reported its Q3 revenues climbed 52% to $12.61 million and net income was up 38% to $4.25 million, which equates to 10 cents per share fully diluted. Growth...
- External links 2008-11-11
- American Oriental Books Another Solid Quarter
- ChinaBio Today submits: American Oriental Bioengineering AOB announced another solid financial performance in Q3. The company’s revenues rose 62% to $70.6 million, and net income was higher by 38% at $16.5 million or 21 cents per diluted share. According to the company, net income failed to keep pace with...
- External links 2008-11-11
Additional Resources
- Biostar Pharma Attributes Big Revenue Gains to Marketing Programs
- ChinaBio Today submits: Biostar Pharmaceuticals (BSPM.OB) reported that 2008 revenues more than doubled to $33.9 million while net income rose 69% to $6.7 million. That is equal to 22 cents per share, fully diluted. The earnings-per-share figure was only a nominal improvement over last year’s 19 cents. Biostar, which...
- External links 2009-04-09
- Genesis Pharma's Q2: Higher Revenue, Flat Net Income
- ChinaBio Today submits: Genesis Pharmaceuticals Enterprises, Inc. (GNPH.OB) reported that revenues jumped 24% during its Q2 (ended December 31, 2008), but net income moved up only 4%. The company booked $32.9 in revenue for the quarter and recorded a profit of $5.4 million or 11 cents per share. Genesis...
- External links 2009-02-17
- China Sky One Admits Under-Reported Revenue
- ChinaBio Today submits: China Sky One Medical (NSDQ: CSKI) (??????????) admitted that its financial reports filed with the State Administration for Industry and Commerce (SAIC) under-reported the income of China Sky One’s China-based subsidiaries. The company said it expects the SAIC to assess a penalty for the misstatements, but...
- External links 2009-08-30
- China Pharma Raises Revenue Guidance on Sales Force Expansion
- ChinaBio Today submits: China Pharma Holdings (CPHI.OB) forecast that its Q3 revenues would grow between 40% and 45% over the year-previous figures. That would be a better performance than Q2, during which revenues climbed 32%. In the first quarter, however, China Pharma reported a 60% jump in its top...
- External links 2008-09-19
- BMP Sunstone Reports Large Q1 Revenue Gain
- ChinaBio Today submits: BMP Sunstone Corporation (NSDQ: BJGP) reported its revenues more than doubled in Q1, rising from $18.1 million last year to $39.3 million in 2009. The company closed its acquisition of Sunstone Pharma in mid-February last year, a deal that transformed BMP Sunstone from a distribution company...
- External links 2009-05-20
- Sinovac Reports 39% Revenue Increase for 2008
- ChinaBio Today submits: Sinovac Biotech Ltd. SVA reported that revenues from its vaccines rose 39% in 2008 to $46.5 million, while net income increased by a relatively small 5% to $8 million. A full 88% of the company’s 2008 sales came from Healive, its hepatitis A vaccine that has...
- External links 2009-04-12
- Sinovac on Track to See Sizable Revenue from Flu Vaccines
- ChinaBio Today submits: Sinovac Biotech SVA has received a very large order for 5.2 million doses of its H1N1 vaccine, Panflu.1. This is the third order Sinovac has received from various official China agencies, bringing the total to 11.5 million doses. Of the 5.2 million doses in the latest...
- External links 2009-10-28
- China Sky One Reports Record Results for Q2
- ChinaBio Today submits: China Sky One Medical (NSDQ: CSKI) reported record high results for Q2 of 2009, and the company reiterated its guidance for full-year 2009. During the second quarter, revenue climbed 36% to $32.2 million, while net income rose 17% to $9.5 million, or 57 cents per share,...
- External links 2009-08-18
- Concord Medical IPO Coming This Week
- ChinaBio Today submits: Concord Medical Services Holdings Ltd. (NYSE: CCM), a company that operates radiation therapy and diagnostic imaging centers in China, plans to raise $126 million for its IPO on December 10. The company claims to be the largest provider of radiotherapy and diagnostic imaging services in China....
- External links 2009-12-06
- China Sky One Increases 2008 Guidance
- ChinaBio Today submits: China Sky One Medical CSKI increased its full-year 2008 revenue and income guidance. The company upped its expectations for 2008 revenue by 9%, rising from $82 million to $89 million. Net income is now predicted to jump 5% higher. Instead of $26.3 million, the company expects...
- External links 2008-09-28
- << Previous
- page 1 of 1
- Next >>
Presented by American Express